Following the decision by the Food and Drug Administration (FDA) in the United States to approve a new drug - aducanumab – for the treatment of Alzheimer’s disease, we've worked with a group of Alzheimer's disease experts to compile a resource of 'Frequently Asked Questions'.
For accurate, reliable and balanced information on this new treatment, and what this recent approval means for people in Scotland, visit our aducanumab page.